https://www.novumpr.nl/2016/04/26/ipsen-is-pleased-to-announce-that-its-partner-exelixis-obtained-fda-approval-of-cabometyx-cabozantinib-tablets-for-patients-with-advanced-renal-cell-carcinoma-who-have-received-prior-anti-a/?utm_source=rss&utm_medium=rss&utm_campaign=ipsen-is-pleased-to-announce-that-its-partner-exelixis-obtained-fda-approval-of-cabometyx-cabozantinib-tablets-for-patients-with-advanced-renal-cell-carcinoma-who-have-received-prior-anti-a NovumPR press releases Tue, 26 Apr 2016 07:39:07 +0000 hourly 1 https://wordpress.org/?v=6.8.3